Learning how and when to employ uricase as bridge therapy in refractory gout

被引：0
|
作者：
Terkeltaub, Robert [1 ]
机构：
[1] Univ Calif San Diego, Vet Affairs Med Ctr, La Jolla, CA 92161 USA
来源：
JOURNAL OF RHEUMATOLOGY | 2007年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1955 / 1958
页数：4
相关论文
共 50 条
  • [1] A recombinant uricase for treatment of chronic gout refractory to conventional therapy
    不详
    [J]. FORMULARY, 2010, 45 (11) : 337 - 337
  • [2] Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
    Baraf, Herbert S. B.
    Yood, Robert A.
    Ottery, Faith D.
    Sundy, John S.
    Becker, Michael A.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (08) : 427 - 432
  • [3] Resolution of tophi with intravenous peg-uricase in refractory gout.
    Baraf, HSB
    Kim, S
    Matsumoto, AK
    Maroli, AN
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S105 - S105
  • [4] PEG-uricase is effective against hyperuricemia in patients with refractory gout
    Katherine Sole
    [J]. Nature Clinical Practice Rheumatology, 2006, 2 (3): : 120 - 121
  • [5] Endovascular Rescue Therapy for Refractory Vasospasm: When and How?
    Weiss, M.
    Schubert, G. A.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2017, 38 (03) : 568 - 569
  • [6] Benzbromarone therapy in management of refractory gout
    Kumar, Sunil
    Ng, Jennifer
    Gow, Peter
    [J]. NEW ZEALAND MEDICAL JOURNAL, 2005, 118 (1217) : 37 - 42
  • [7] Population pharmacokinetic and pharmacodynamic analysis of PEG-uricase in subjects with hyperuricemia and refractory gout.
    Yue, C. Seng
    Marier, J. F.
    Huang, B.
    Alton, M.
    Maroli, A. N.
    Wright, D.
    Di Marco, M.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1074 - 1074
  • [8] Stopping progression to tophaceous gout - When and how to use urate-lowering therapy
    McDonald, E
    Marino, C
    [J]. POSTGRADUATE MEDICINE, 1998, 104 (06) : 117 - +
  • [9] Hybrid therapy as an alternative in refractory atrial fibrillation: When, why, and how?
    Saksena, S.
    Skadsberg, N.
    [J]. CARDIAC ARRHYTHMIAS 2005, 2005, : 267 - 278
  • [10] HOW TO MANAGE GOUT WHEN COMPLICATED WITH LITHIASIS
    COTTET, J
    RYCKEWAERT, A
    HAMBURGER, J
    PEQUIGNOT, H
    RICHET, G
    MILLIEZ, P
    [J]. PRESSE MEDICALE, 1961, 69 (34): : 1557 - &
12345